Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1565)
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
6,350
Price
$4.61
Total Value
$29.27K
Shares Held After
2,843,571
% of Holdings
0.2%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Soares Karen — Chief Legal Officer
Shares
4,681
Price
$4.61
Total Value
$21.58K
Shares Held After
1,567,741
% of Holdings
0.3%
111, Inc. (YI)
Sun Jian David — Director
Shares
58,800
Price
$0.23
Total Value
$13.52K
Shares Held After
413,211
% of Holdings
12.5%
111, Inc. (YI)
Chen Yang Luke — Director
Shares
44,000
Price
$0.23
Total Value
$10.12K
Shares Held After
495,462
% of Holdings
8.2%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
3,666
Price
$3.58
Total Value
$13.12K
Shares Held After
132,715
% of Holdings
2.7%
Alignment Healthcare, Inc. (ALHC)
Maroney Dawn Christine — President
Shares
30,000
Price
$19.55
Total Value
$586.42K
Shares Held After
947,313
% of Holdings
3.1%
ABEONA THERAPEUTICS INC. (ABEO)
Silverstein Christine Berni — Director
Shares
18,160
Price
$5.71
Total Value
$103.70K
Shares Held After
119,562
% of Holdings
13.2%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
600
Price
$69.69
Total Value
$41.81K
Shares Held After
236,384
% of Holdings
0.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
733
Price
$69.69
Total Value
$51.08K
Shares Held After
31,034
% of Holdings
2.3%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
1,899
Price
$24.62
Total Value
$46.75K
Shares Held After
94,462
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Sanders Corazon (Corsee) D. — Director
Shares
2,000
Price
$25.05
Total Value
$50.10K
Shares Held After
21,095
% of Holdings
8.7%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
1,729
Price
$69.69
Total Value
$120.49K
Shares Held After
925,580
% of Holdings
0.2%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
947
Price
$69.69
Total Value
$66.00K
Shares Held After
32,718
% of Holdings
2.8%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
300
Price
$70.62
Total Value
$21.19K
Shares Held After
33,665
% of Holdings
0.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
5,064
Price
$69.42
Total Value
$351.55K
Shares Held After
33,965
% of Holdings
13.0%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
1,636
Price
$68.38
Total Value
$111.88K
Shares Held After
39,029
% of Holdings
4.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
395
Price
$69.69
Total Value
$27.53K
Shares Held After
16,899
% of Holdings
2.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$70.46
Total Value
$528.45K
Shares Held After
385,330
% of Holdings
1.9%
Ridgetech Inc. (RDGT)
HRT FINANCIAL LP — 10% Owner
Shares
6,526
Price
$1.51
Total Value
$9.85K
Shares Held After
127,842
% of Holdings
4.9%
Clearmind Medicine Inc. (CMND)
HRT FINANCIAL LP — 10% Owner
Shares
2,102
Price
$3.36
Total Value
$7.06K
Shares Held After
106,675
% of Holdings
1.9%
111, Inc. (YI)
Chen Yang Luke — Director
Shares
49,920
Price
$0.23
Total Value
$11.48K
Shares Held After
539,462
% of Holdings
8.5%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
12,996
Price
$3.94
Total Value
$51.20K
Shares Held After
136,381
% of Holdings
8.7%
LIGAND PHARMACEUTICALS INC (LGND)
Haas Jason — Director
Shares
3,461
Price
$256.08
Total Value
$886.29K
Shares Held After
4,981
% of Holdings
41.0%
LIGAND PHARMACEUTICALS INC (LGND)
Haas Jason — Director
Shares
3,000
Price
$255.01
Total Value
$765.03K
Shares Held After
8,442
% of Holdings
26.2%
PUMA BIOTECHNOLOGY, INC. (PBYI)
Senderowicz Adrian — Director
Shares
27,000
Price
$7.20
Total Value
$194.31K
Shares Held After
27,000
% of Holdings
50.0%
PUMA BIOTECHNOLOGY, INC. (PBYI)
Stuglik Brian M — Director
Shares
8,100
Price
$7.20
Total Value
$58.31K
Shares Held After
113,858
% of Holdings
6.6%
PUMA BIOTECHNOLOGY, INC. (PBYI)
MOYES JAY M — Director
Shares
22,000
Price
$7.22
Total Value
$158.80K
Shares Held After
58,322
% of Holdings
27.4%
PUMA BIOTECHNOLOGY, INC. (PBYI)
WILSON TROY EDWARD — Director
Shares
10,800
Price
$7.20
Total Value
$77.75K
Shares Held After
59,750
% of Holdings
15.3%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
1,654
Price
$2.23
Total Value
$3.69K
Shares Held After
505,094
% of Holdings
0.3%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
2,584
Price
$2.23
Total Value
$5.77K
Shares Held After
512,319
% of Holdings
0.5%
PUMA BIOTECHNOLOGY, INC. (PBYI)
Dorval Allison — Director
Shares
11,610
Price
$7.20
Total Value
$83.58K
Shares Held After
90,780
% of Holdings
11.3%
ANI PHARMACEUTICALS INC (ANIP)
Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Shares
500
Price
$82.03
Total Value
$41.02K
Shares Held After
77,890
% of Holdings
0.6%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
3,260
Price
$70.34
Total Value
$229.31K
Shares Held After
17,294
% of Holdings
15.9%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,340
Price
$69.85
Total Value
$303.15K
Shares Held After
20,554
% of Holdings
17.4%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
1,859
Price
$68.34
Total Value
$127.05K
Shares Held After
24,894
% of Holdings
6.9%
Alignment Healthcare, Inc. (ALHC)
Kim Hyong — Chief Medical Officer
Shares
35,951
Price
$19.86
Total Value
$713.95K
Shares Held After
331,750
% of Holdings
9.8%
Elevance Health, Inc. (ELV)
Penczek Ronald W — CAO & Controller
Shares
369
Price
$403.16
Total Value
$148.77K
Shares Held After
3,740
% of Holdings
9.0%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
5,000
Price
$4.95
Total Value
$24.75K
Shares Held After
245,780
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
743
Price
$545.71
Total Value
$405.46K
Shares Held After
40,513
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$544.45
Total Value
$304.89K
Shares Held After
41,256
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$543.03
Total Value
$130.33K
Shares Held After
41,816
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,797
Price
$542.40
Total Value
$974.69K
Shares Held After
42,056
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,671
Price
$541.23
Total Value
$904.39K
Shares Held After
43,853
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,154
Price
$540.46
Total Value
$1.70M
Shares Held After
45,524
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
535
Price
$539.24
Total Value
$288.49K
Shares Held After
48,678
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$538.43
Total Value
$215.91K
Shares Held After
49,213
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
399
Price
$537.40
Total Value
$214.42K
Shares Held After
49,614
% of Holdings
0.8%
UFP TECHNOLOGIES INC (UFPT)
FELDMANN CYNTHIA L — Director
Shares
100
Price
$240.40
Total Value
$24.04K
Shares Held After
5,476
% of Holdings
1.8%
UFP TECHNOLOGIES INC (UFPT)
FELDMANN CYNTHIA L — Director
Shares
1,100
Price
$239.19
Total Value
$263.11K
Shares Held After
5,576
% of Holdings
16.5%
ARS Pharmaceuticals, Inc. (SPRY)
Karas Eric — Chief Commercial Officer
Shares
25,000
Price
$10.00
Total Value
$250.00K
Shares Held After
12,176
% of Holdings
67.2%
Showing 1–50 of 1565 transactions (page 1 of 32)